Forte Biosciences (FBRX)

• Market cap: $1.57B
• 1 day: -0.49%
• 5 days: 0.25%
• 1 month: 260.47%
• 3 months: 187.32%
• 6 months: 122.09%
• Year to date: 224.44%
• 1 year: 667.54%
• 5 years: -89.92%
• 10 years: -98.36%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Employees: 22